Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chatswood, Australia Clinical Trials

A listing of Chatswood, Australia clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Renal cell carcinoma (RCC) is the 9th most common cancer in Australia, the 10th most common cancer in Western populations.~75% of kidney cancers are clear-cell renal cell carcinomas (ccRCC). Many patients present with advanced or unresectable disease at diagnosis and a number of treatments are now available for metastatic ccRCC ...

Phase

1.73 miles

Learn More »

A Biomarker-directed Study of XPro1595 in Patients With Mild to Moderate Alzheimer's

The study is designed as a multicentre, phase 1b open-label study. The objectives of this study are to determine the safety, tolerability, and efficacy of XPro1595 in patients with mild to moderate Alzheimer's disease and elevated blood levels of the inflammatory biomarker high sensitivity c-reactive protein (hs-CRP). XPro1595 is a ...

Phase

2.64 miles

Learn More »

Cephea Transseptal Mitral Valve System FIH

To assess the safety and performance of the Cephea Transseptal Mitral Valve System for the treatment of symptomatic moderate to severe degenerative or functional mitral regurgitation, in patients who are poor candidates for surgery.

Phase N/A

5.0 miles

Learn More »

Pharmacokinetics Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

AVT02 is being developed as a biosimilar to Humira. EU-Humira and US-Humira have therefore been selected as the active control groups in this study. This study is designed as a multi-center, randomised, double-blind, 3-arm parallel study of AVT02 compared to EU-Humira and US-Humira in healthy adult subjects. The study is ...

Phase

8.43 miles

Learn More »